is a corporate lawyer with a main focus on the life sciences sector. Amber has a background in intellectual property law and provides transactional and regulatory support to clients active in the pharmaceutical and medical-devices sector. Her main areas of expertise comprise transactional and regulatory assistance throughout the entire product life cycle, from negotiating and drafting contracts, co-ordination of international R&D collaborations (the Horizon 2020 funding programme, the Innovative Medicines Initiative (IMI2) programme, to clinical phases, marketing authorisations, advertising and promotion, pricing and reimbursement, and interactions with healthcare professionals and healthcare organisations.
Chambers and Partners make no representation or endorsement of the quality and services supplied
by companies or firms that may be found on this website. In no event will Chambers and Partners
be liable for any damages including, without limitation, indirect or consequential damages,
or any damages whatsoever arising from use or loss of use, data, or profits, whether in action
of contract, negligence or other tort action, arising out of or in connection with the use
of the website.